4
Changes in Ownership
agilon health, inc. Filed Acc 0001209191-22-041801
Chief Strategy & Dev. Officer sold 319,071 shares at $25.00 ($7,976,775)
- Chief Strategy & Dev. Officer acquired 319,071 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Desai Veeral Chief Strategy & Dev. Officer | 2022-07-07 | Option exercise | +319,071 | $1.00 | $319,071 | 597,282 | D: show line 1 in the form |
| Desai Veeral Chief Strategy & Dev. Officer | 2022-07-07 | Sale | −319,071 | $25.00 | $7,976,775 | 278,211 | D: show line 2 in the form |
| Open-market sales · 319,071 sh · avg $25.00 · $7,976,775 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Desai Veeral Chief Strategy & Dev. Officer | 2022-07-07 | Option exercise · Options (Rights to Buy) | −319,071 | 137,209 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…